Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medtronic Inc (MDT)

Medtronic Inc (MDT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 118,263,648
  • Shares Outstanding, K 1,282,686
  • Annual Sales, $ 33,537 M
  • Annual Income, $ 4,662 M
  • EBIT $ 7,972 M
  • EBITDA $ 10,833 M
  • 60-Month Beta 0.77
  • Price/Sales 3.44
  • Price/Cash Flow 11.62
  • Price/Book 2.40

Options Overview Details

View History
  • Implied Volatility 27.14% ( +1.21%)
  • Historical Volatility 15.62%
  • IV Percentile 94%
  • IV Rank 48.99%
  • IV High 41.66% on 04/08/25
  • IV Low 13.20% on 02/04/25
  • Put/Call Vol Ratio 0.21
  • Today's Volume 9,581
  • Volume Avg (30-Day) 9,835
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 242,618
  • Open Int (30-Day) 210,993

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 31 analysts offering recommendations.
Earnings Estimates - Current Qtr 10/31/25
See More
  • Average Estimate 1.31
  • Number of Estimates 11
  • High Estimate 1.32
  • Low Estimate 1.31
  • Prior Year 1.26
  • Growth Rate Est. (year over year) +3.97%

Price Performance

See More
Period Period Low Period High Performance
1-Month
89.04 +3.55%
on 11/03/25
98.68 -6.57%
on 10/08/25
-6.13 (-6.23%)
since 10/07/25
3-Month
87.50 +5.37%
on 08/19/25
99.37 -7.22%
on 10/07/25
+0.96 (+1.05%)
since 08/07/25
52-Week
79.29 +16.28%
on 12/30/24
99.37 -7.22%
on 10/07/25
+4.08 (+4.63%)
since 11/07/24

Most Recent Stories

More News
Medtronic to announce financial results for its second quarter of fiscal year 2026

GALWAY, Ireland , Nov. 5, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, November 18,...

MDT : 92.20 (+2.38%)
Is Wall Street Bullish or Bearish on Medtronic Stock?

Despite underperforming the market over the past year, Medtronic still enjoys fairly upbeat outlook from analysts.

XHE : 80.80 (+1.70%)
$SPX : 6,728.80 (+0.13%)
MDT : 92.20 (+2.38%)
U.S. Centers for Medicare & Medicaid Services finalizes National Coverage Determination for the Medtronic Symplicity Spyralâ„¢ renal denervation (RDN) system

Symplicity blood pressure procedure is now covered for qualifying Medicare patients

MDT : 92.20 (+2.38%)
What to Expect From Medtronic's Q2 2026 Earnings Report

Medtronic is expected to release its second-quarter results next month, and analysts project a single-digit earnings increase.

ABT : 126.36 (+1.13%)
XLV : 146.14 (+0.14%)
$SPX : 6,728.80 (+0.13%)
MDT : 92.20 (+2.38%)
Three-year SPYRAL HTN-ON MED results show sustained, 18 mmHg office-based blood pressure reductions

Long-term data shows significant and sustained blood pressure reductions in both office-based and 24-hour ambulatory blood pressure, reinforcing the durability, safety and effectiveness of the Symplicityâ„¢...

MDT : 92.20 (+2.38%)
What You Need to Know Ahead of Stryker's Earnings Release

Stryker will release its third-quarter earnings later this month, and analysts anticipate a high single-digit bottom-line growth.

ZBH : 88.50 (-0.01%)
XLV : 146.14 (+0.14%)
SYK : 356.03 (+0.63%)
$SPX : 6,728.80 (+0.13%)
JNJ : 186.57 (-0.21%)
MDT : 92.20 (+2.38%)
Leerink Partners Remains a Buy on Medtronic (MDT)

Leerink Partners analyst Mike Kratky maintained a Buy rating on Medtronic on October 14 and set a price target of $114.00. The company’s shares closed yesterday at $95.34.Elevate Your Investing Strategy:...

MDT : 92.20 (+2.38%)
Analysts Conflicted on These Healthcare Names: Avidity Biosciences (RNA), Medtronic (MDT) and Pfizer (PFE)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Avidity Biosciences (RNA – Research Report), Medtronic (MDT – Research Report) and Pfizer (PFE – Research Report).Elevate...

RNA : 69.84 (+0.09%)
MDT : 92.20 (+2.38%)
PFE : 24.43 (+0.04%)
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Neogen (NEOG), Medtronic (MDT) and Merck & Company (MRK)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Neogen (NEOG – Research Report), Medtronic (MDT – Research Report) and Merck & Company (MRK – Research Report).Elevate...

MRK : 86.28 (+0.58%)
NEOG : 6.40 (+7.02%)
MDT : 92.20 (+2.38%)
Medtronic BrainSenseâ„¢ Adaptive Deep Brain Stimulation named a 2025 TIME Best Inventions

TIME Best Inventions honors extraordinary innovations changing lives

MDT : 92.20 (+2.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 30%. The market has bounced from oversold territory. Beware of a potential mean reversion.

See More Share

Business Summary

Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience...

See More

Key Turning Points

3rd Resistance Point 94.94
2nd Resistance Point 93.59
1st Resistance Point 92.89
Last Price 92.20
1st Support Level 90.85
2nd Support Level 89.50
3rd Support Level 88.81

See More

52-Week High 99.37
Last Price 92.20
Fibonacci 61.8% 91.70
Fibonacci 50% 89.33
Fibonacci 38.2% 86.96
52-Week Low 79.29

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar